enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Ghada El-Hajj Fuleihan - Wikipedia

   en.wikipedia.org/wiki/Ghada_El-Hajj_Fuleihan

   El-Hajj Fuleihan is a professor at the Department of Internal Medicine at the American University of Beirut [6] and is founding director of the Calcium Metabolism and Osteoporosis Program, World Health Organization (WHO) Collaborating Center for Metabolic Bone Disorders, and AUB's Scholars in HeAlth Research Program.

3. National Institute of Arthritis and Musculoskeletal and Skin ...

   en.wikipedia.org/wiki/National_Institute_of...

   The Scientific Review Branch (SRB) conducts the initial peer review of specific research applications assigned to the NIAMS. These include applications for Centers, program projects, single and multi-site clinical trials, scientific conferences, training and career development awards, as well as applications responding to initiatives published ...

4. Osteoporosis International - Wikipedia

   en.wikipedia.org/wiki/Osteoporosis_International

   It is an official journal of the International Osteoporosis Foundation and the National Osteoporosis Foundation. [3] The journal is published monthly and includes original research on all areas of osteoporosis and its related fields, alongside reviews, educational articles, and case reports. The co-editors-in-chief are J.A. Kanis and F. Cosman.

5. Knee pain in the US increased 65% over the past 20 years ...

   www.aol.com/help-knees-doing-easy-exercises...

   The regimen was deemed significantly effective at reducing pain associated with knee osteoarthritis and osteoporosis, back pain, and neck pain in a systematic review published in the March 2022 ...

6. Romosozumab - Wikipedia

   en.wikipedia.org/wiki/Romosozumab

   Romosozumab is used for osteoporosis to decrease the risk of fractures. [10] Two trials found that it reduced the rate of vertebral fracture. In one, there was a 73% lower risk of vertebral fracture after one year, and the benefit was maintained after a second year of taking denosumab.

7. Nancy E. Lane - Wikipedia

   en.wikipedia.org/wiki/Nancy_E._Lane

   While at UC Davis, Lane focuses on the treatment of patients with osteoporosis, specifically glucocorticoid-induced osteoporosis aetiology. She has also sat on the editorial boards of Nature Reviews Rheumatology, Rheumatology, Seminars in Arthritis and Rheumatism, Arthritis & Rheumatology, and The Journal of Rheumatology. [1]